List of Excipients in API NALOXONE HYDROCHLORIDE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing NALOXONE HYDROCHLORIDE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Adamis Pharmaceuticals | ZIMHI | naloxone hydrochloride | 38739-600 | HYDROCHLORIC ACID | |
| Adamis Pharmaceuticals | ZIMHI | naloxone hydrochloride | 38739-600 | SODIUM CHLORIDE | |
| Adamis Pharmaceuticals | ZIMHI | naloxone hydrochloride | 38739-600 | WATER | |
| Summit Biosciences Inc | REZENOPY | naloxone hydrochloride | 43674-004 | GLYCERIN | |
| Summit Biosciences Inc | REZENOPY | naloxone hydrochloride | 43674-004 | HYDROCHLORIC ACID | |
| Summit Biosciences Inc | REZENOPY | naloxone hydrochloride | 43674-004 | SODIUM HYDROXIDE | |
| Summit Biosciences Inc | REZENOPY | naloxone hydrochloride | 43674-004 | TRISODIUM CITRATE DIHYDRATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing NALOXONE HYDROCHLORIDE
Detailed excipient profiles for NALOXONE HYDROCHLORIDE
Excipient focus: BENZALKONIUM CHLORIDE
NALOXONE HYDROCHLORIDE drug variants containing BENZALKONIUM CHLORIDE
NALOXONE HYDROCHLORIDE drug variants not containing BENZALKONIUM CHLORIDE
Excipient focus: EDETATE DISODIUM
NALOXONE HYDROCHLORIDE drug variants containing EDETATE DISODIUM
NALOXONE HYDROCHLORIDE drug variants not containing EDETATE DISODIUM
Excipient focus: GLYCERIN
NALOXONE HYDROCHLORIDE drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Summit Biosciences Inc | naloxone hydrochloride | 43674-004 |
| >Company | >Ingredient | >NDC |
NALOXONE HYDROCHLORIDE drug variants not containing GLYCERIN
Excipient focus: HYDROCHLORIC ACID
NALOXONE HYDROCHLORIDE drug variants containing HYDROCHLORIC ACID
NALOXONE HYDROCHLORIDE drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Lake Erie Medical DBA Quality Care Products LLC | naloxone hydrochloride | 55700-457 |
| Mylan Institutional LLC | naloxone hydrochloride | 67457-992 |
| International Medication Systems Ltd | naloxone hydrochloride | 76329-3669 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
NALOXONE HYDROCHLORIDE drug variants containing METHYLPARABEN
NALOXONE HYDROCHLORIDE drug variants not containing METHYLPARABEN
Excipient focus: NITROGEN
NALOXONE HYDROCHLORIDE drug variants containing NITROGEN
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | naloxone hydrochloride | 43598-750 |
| HF Acquisition Co LLC DBA HealthFirst | naloxone hydrochloride | 51662-1529 |
| Meitheal Pharmaceuticals Inc | naloxone hydrochloride | 71288-814 |
| >Company | >Ingredient | >NDC |
NALOXONE HYDROCHLORIDE drug variants not containing NITROGEN
Excipient focus: PROPYLPARABEN
NALOXONE HYDROCHLORIDE drug variants containing PROPYLPARABEN
NALOXONE HYDROCHLORIDE drug variants not containing PROPYLPARABEN
Excipient focus: SODIUM CHLORIDE
NALOXONE HYDROCHLORIDE drug variants containing SODIUM CHLORIDE
NALOXONE HYDROCHLORIDE drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Summit Biosciences Inc | naloxone hydrochloride | 43674-004 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
NALOXONE HYDROCHLORIDE drug variants containing SODIUM HYDROXIDE
NALOXONE HYDROCHLORIDE drug variants not containing SODIUM HYDROXIDE
Excipient focus: TRISODIUM CITRATE DIHYDRATE
NALOXONE HYDROCHLORIDE drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Summit Biosciences Inc | naloxone hydrochloride | 43674-004 |
| Harm Reduction Therapeutics Inc | naloxone hydrochloride | 82954-0100 |
| >Company | >Ingredient | >NDC |
NALOXONE HYDROCHLORIDE drug variants not containing TRISODIUM CITRATE DIHYDRATE
Excipient focus: WATER
NALOXONE HYDROCHLORIDE drug variants containing WATER
NALOXONE HYDROCHLORIDE drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch